Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer Journal Article


Authors: Leitner, S. P.; Casper, E. S.; Hakes, T. B.; Kaufman, R. J.; Winn, R. J.; Scoppetuolo, M.; Raymond, V.; Geller, N. L.; Young, C. W.
Article Title: Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer
Abstract: 4'-Deoxydoxorubicin (25 mg/m2 iv every 3 weeks) was evaluated in 20 patients with advanced breast cancer. The patients had good performance status and had not been heavily pretreated. Although all patients experienced leukopenia, no major therapeutic responses were observed. Nonhematologic toxicity was mild. Further evaluation of 4'-deoxydoxorubicin at this dose and schedule is not warranted in patients with advanced breast cancer.
Keywords: adult; cancer chemotherapy; clinical article; aged; middle aged; prednisone; doxorubicin; fluorouracil; drug efficacy; methotrexate; phase 2 clinical trial; breast cancer; breast; leukopenia; nausea; thrombocytopenia; cyclophosphamide; vincristine; breast neoplasms; drug therapy; heart left ventricle ejection fraction; heart; adverse drug reaction; therapy; intravenous drug administration; hair loss; drug evaluation; humans; human; female; priority journal; esorubicin; blood and hemopoietic system
Journal Title: Cancer Treatment Reports
Volume: 69
Issue: 11
ISSN: 0361-5960
Publisher: National Cancer Institute  
Date Published: 1985-11-01
Start Page: 1319
End Page: 1320
Language: English
PROVIDER: scopus
PUBMED: 4092194
DOI/URL:
Notes: Article -- Export Date: 26 October 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Ephraim S Casper
    108 Casper
  2. Charles W Young
    82 Young
  3. Thomas B Hakes
    115 Hakes
  4. Richard J Kaufman
    13 Kaufman
  5. Nancy L. Geller
    65 Geller